Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours

Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours

Bibliographic Details
Main Authors:	Mendoza, J, Martínez, J, Hernández, C, Pérez-Montiel, D, Castro, C, Fabián-Morales, E, Santibáñez, M, González-Barrios, R, Díaz-Chávez, J, Andonegui, M A, Reynoso, N, Oñate, L F, Jiménez, M A, Núñez, M, Dyer, R, Herrera, L A
Format:	Online
Language:	English
Published:	Nature Publishing Group 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708571/

Similar Items

Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction
by: Barakat, Khaled H., et al.
Published: (2012)

ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines
by: Weaver, David A, et al.
Published: (2005)

MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors
by: López-Saavedra, Alejandro, et al.
Published: (2016)

Analysis of the XPA and ssDNA-binding surfaces on the central domain of human ERCC1 reveals evidence for subfunctionalization
by: Tripsianes, Konstantinos, et al.
Published: (2007)

ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
by: Chen, Liang, et al.
Published: (2016)

Redefining the DNA-Binding Domain of Human XPA
by: Sugitani, Norie, et al.
Published: (2014)

Imaging of testicular germ cell tumours
by: Dalal, P U, et al.
Published: (2006)

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
by: Burger, H., et al.
Published: (1998)

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
by: Hadeel Obiedat, et al.
Published: (2018-07-01)

Glycolipids of human primary testicular germ cell tumours.
by: Olie, R. A., et al.
Published: (1996)

Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
by: Nitzsche, B, et al.
Published: (2012)

Scrotal Involvement with Testicular Nonseminomatous Germ Cell Tumour
by: O'Leary, C. G., et al.
Published: (2016)

Geographical epidemiology of ovarian and testicular germ cell cancers.
by: Kamdar, R. H., et al.
Published: (1998)

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
by: Schaapveld, M, et al.
Published: (2012)

TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts
by: Kucab, Jill E., et al.
Published: (2015)

Bone disease in testicular and extragonadal germ cell tumours.
by: Hitchins, R. N., et al.
Published: (1988)

Microsatellite instability in human testicular germ cell tumours.
by: Huddart, R. A., et al.
Published: (1995)

p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
by: Gutekunst, Matthias, et al.
Published: (2011)

A new structural insight into XPA–DNA interactions
by: Hilton, Benjamin, et al.
Published: (2014)

Increased incidence of germ cell testicular cancer in New Zealand Maoris.
by: Wilkinson, T. J., et al.
Published: (1992)

Association of metallothionein expression and clinical response to cisplatin based chemotherapy in testicular germ cell tumors
by: Tuzel, Emre, et al.
Published: (2015)

Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer.
by: dos Santos Silva, I., et al.
Published: (1991)

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
by: Bokemeyer, C., et al.
Published: (1998)

Familial testicular germ cell tumor: no associated syndromic pattern identified
by: Mueller, Christine M, et al.
Published: (2014)

SEOM clinical guidelines for the management of germ cell testicular cancer (2016)
by: Aparicio, J., et al.
Published: (2016)

“Mixed germ cell testicular tumor” in an adult female
by: Shivakumarswamy, Udasimath, et al.
Published: (2012)

Cutaneous metastasis from testicular germ cell tumour
by: Joel, Anjana, et al.
Published: (2014)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
by: Li, Yangkai, et al.
Published: (2013)

N-cadherin Expression in Testicular Germ Cell and Gonadal Stromal Tumors
by: Heidenberg, Daniel J., et al.
Published: (2012)

Hernia uterine inguinale with transverse testicular ectopia and mixed germ cell tumor
by: Jaka, Rajshekhar C., et al.
Published: (2007)

Frequent PD-L1 expression in testicular germ cell tumors
by: Fankhauser, C D, et al.
Published: (2015)

CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients
by: Park, S R, et al.
Published: (2011)

Long-term sequelae of treatment for testicular germ cell tumours.
by: Bissett, D., et al.
Published: (1990)

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin
by: Tiseo, M, et al.
Published: (2013)

Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia.
by: Klys, H. S., et al.
Published: (1992)

β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK
by: LI, QUENTIN Q., et al.
Published: (2013)

Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
by: Cavallo, Francesca, et al.
Published: (2012)

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors
by: Koul, Sanjay, et al.
Published: (2004)

Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
by: Juliachs, Mercè, et al.
Published: (2013)

Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
by: Willemse, P M, et al.
Published: (2013)